-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Inmune Bio, Inc. annual/quarterly Nonoperating Income (Expense) history and growth rate from 2020 to 2024.
- Inmune Bio, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $193K.
- Inmune Bio, Inc. annual Nonoperating Income (Expense) for 2024 was $553K.
- Inmune Bio, Inc. annual Nonoperating Income (Expense) for 2023 was -$267K.
- Inmune Bio, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.19M, a 1020% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)